Exegiline Company Profile, Contacts & Intelligence

Exegiline Overview

Exegiline is developing a novel oral drug, MT-31, for the treatment of the symptoms related to Alzheimer’s Disease. MT-31 structure combines Rivastigmine (Exelon) with Rasagiline’s (Azilect) propargyl moiety having unique beneficial properties. MT-31, its derivatives and indication, are protected by a recently granted US and EP patents.

Website

www.exegiline.com

Industry

Pharmaceutical Manufacturing

NAICS

Pharmaceutical and Medicine Manufacturing, Medicinal and Botanical Manufacturing

Exegiline Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

Exegiline People & Org Chart Preview

Sample people records show job titles and whether email or phone data is available without exposing raw contact details.

Compare Similar Companies to Exegiline

Explore companies in related markets and compare their industry and employee estimates.